Agfa moves to shed NDT business

Article

Agfa-Gevaert will divest its nondestructive testing business group to GE Aircraft Engines. The transaction is pending the receipt of regulatory approvals. The NDT group, comprising more than 1000 employees, provides analog and digital x-ray and

Agfa-Gevaert will divest its nondestructive testing business group to GE Aircraft Engines. The transaction is pending the receipt of regulatory approvals. The NDT group, comprising more than 1000 employees, provides analog and digital x-ray and ultrasonic inspection systems to test the structure and tolerance of industrial materials. In 2002, Agfa's NDT customers in the aerospace, automotive, railway, energy, and petrochemical industries generated revenues of approximately Euro 220 million. These revenues represented about 4.5% of Agfa sales. The agreement with GE covers all Agfa NDT activities except the production of x-ray film, for which Agfa and GE have concluded a long-term supply agreement. Under this agreement, GE will become the exclusive distributor of Agfa industrial x-ray film.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.